CMBA
BXC icon

C.M. Bidwell & Associates’s BlueLinx BXC Stock Holding History

C.M. Bidwell & Associates’s Portfolio BXC Stock Details BXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-395
Closed -$19K – 556
2021
Q3 		$19K Hold
395
– – 0.01% 356
2021
Q2 		$20K Hold
395
– – 0.01% 350
2021
Q1 		$15K Hold
395
– – 0.01% 360
2020
Q4 		$12K Buy
+395
New +$10.1K 0.01% 365

Other funds holding BXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

C.M. Bidwell & Associates's BXC Position: Q4 2021 in Review

C.M. Bidwell & Associates sold out of BlueLinx (BXC) in Q4 2021, closing a stake of 395 shares — an estimated $19K sold.

C.M. Bidwell & Associates first reported a position in BXC in Q4 2020 and held it in 4 quarters. The position peaked at $20K in Q2 2021. 150 funds tracked by Wall St. Rank hold BXC as of Q4 2021.

  • C.M. Bidwell & Associates reported no remaining BlueLinx position as of Q4 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 395 BlueLinx shares in Q4 2021, an estimated $19K.
  • C.M. Bidwell & Associates first reported a position in BlueLinx in Q4 2020 and held it in 4 quarters.
  • C.M. Bidwell & Associates's BlueLinx position peaked at $20K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held BlueLinx as of Q4 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.